Novus In the News

August 3, 2013 - MiBiz: Novus raises $2 million towards goal

October 13, 2013 - MiBiz: 
New VC fund targets med device startups

Portfolio Companies

                                       Ablative Solutions addresses a significant unmet
                                       medical need. Its technology utilizes endovascular
                                       catheters to provide an efficacious, durable, cost-effective and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.

                                       Trice Medicalâ„¢ was founded to fundamentally improve
                                       orthopedic diagnostics for the patient, physician, and
                                       payor by providing instant, eyes-on, answers.  Trice has pioneered fully integrated camera-enabled technologies that provide a clinical solution that is optimized for the physicians office.  Our mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system.

Novus Biotechnology Fund I is managed by Charter Capital Partners.